{"status":"success","data":{"title":"Does Your Dyspneic Patient Have CHF?","slug":"does-your-pt-have-chf","tags":null,"collection":["cardiovascular","ebm"],"content":"\n# Does your dyspneic patient have CHF?\n\n[McCullough et al: ED patients WITH a history of asthma or COPD](https://www.ncbi.nlm.nih.gov/pubmed/?term=12615582)\n\n(NS = not significant because LR crosses 1.0)\n\n<table>\n  <tr>\n    <th>Finding</th>\n    <th>Positive LR</th>\n    <th>Negative LR</th>\n  </tr>\n  <tr>\n    <td>Initial Clinical Judgement</td>\n    <td>**9.5** (5.3-18)</td>\n    <td>0.65 (0.55-0.77)</td>\n  </tr>\n  <tr>\n    <td>\n      History\n      <ul>\n        <li>Atrial fibrillation </li>\n        <li>CABG</li>\n        <li>Diabetes mellitus</li>\n        <li>CAD</li>\n        <li>Hypertension</li>\n      </ul>\n    </td>\n    <td>\n      <br>\n      <ul>\n        <li>**4.1** (2.5-6.6)</li>\n        <li>2.8 (1.3-5.8)</li>\n        <li>2.0 (1.3-3.2)</li>\n        <li>2.0 (1.5-2.6)</li>\n        <li>NS</li>\n      </ul>\n    </td>\n    <td>\n      <br>\n      <ul>\n        <li>0.74 (0.63-0.85)</li>\n        <li>0.92 (0.84-0.99)</li>\n        <li>0.85 (0.74-0.97)</li>\n        <li>0.67 (0.54-0.84)</li>\n        <li>NS</li>\n      </ul>\n    </td>\n  </tr>\n  <tr>\n    <td>\n      Symptoms\n      <ul>\n        <li>Orthopnea</li>\n        <li>Nocturnal cough</li>\n        </ul>\n    </td>\n    <td>\n      <br>\n      <ul>\n        <li>1.3 (1.1-1.5)</li>\n        </li>NS</li>\n      </ul>\n    </td>\n    <td>\n      <br>\n      <ul>\n        <li>0.68 (0.48-0.95)</li>\n        <li>NS</li>\n      </ul>\n    </td>\n  </tr>\n  <tr>\n    <td>\n      Physical exam\n      <ul>                    \n       <li>S3 (ventricular filling gallop)</li>\n       <li>JVD</li>\n       <li>Leg edema</li>\n       <li>Rales</li>\n       <li>Hepatic congestion</li>\n       <li>Cardiomegaly</li>\n       <li>Wheezing</li>\n      </ul>\n    </td>\n    <td>\n      <br>\n      <ul>\n        <li>**57.0** (7.6-425)</li>\n        <li>**4.3** (2.8-6.5)</li>\n        <li>2.7 (2.2-3.5)</li>\n        <li>2.6 (1.2-4.7)</li>\n        <li>2.4 (1.2-4.7)</li>\n        <li>NS</li>\n        <li>NS</li>\n    </td>\n    <td>\n      <br>\n      <ul>\n        <li>0.83 (0.75-0.91)</li>\n        <li>0.65 (0.54-0.78)</li>\n        <li>0.41 (0.30-0.57)</li>\n        <li>0.39 (0.28-0.55)</li>\n        <li>0.91 (0.84-1.0)</li>\n        <li>NS</li>\n        <li>NS</li>\n      </ul>\n    </td>\n  </tr>\n    <td>\n      Chest radiograph\n      <ul>\n       <li>Pulmonary edema</li>\n       <li>Cardiomegaly</li>\n       <li>Pleural effusion</li>\n       <li>Pneumonia</li>\n       <li>Hyperinflation</li>\n       <li>Normal</li>\n      </ul>\n    </td>\n    <td>\n      <br>\n      <ul>\n        <li>**11.0** (5.8-22.0)</li>\n        <li>**7.1** (4.5-11.0)</li>\n        <li>**4.6** (2.6-8.0)</li>\n        <li>NS</li>\n        <li>NS</li>\n        <li>0.11 (0.04-0.28)</li>\n      </ul>\n    </td>\n    <td>\n      <br>\n      <ul>\n        <li>0.68 (0.58-0.79)</li>\n        <li>0.54 (0.44-0.67)</li>\n        <li>0.78 (0.69-0.89)</li>\n        <li>NS</li>\n        <li>NS</li>\n        <li>1.7 (1.5-1.8)</li>\n      </ul>\n    </td>\n  </tr>\n  <tr>\n    <td>\n      EKG\n      <ul>                               \n        <li>Atrial fibrillation</li>\n        <li>Ischemic ST-T waves</li>\n        <li>Q waves</li>\n       </ul>\n     </td>\n     <td>\n      <br>\n      <ul>\n        <li>**6.0** (3.4-10.0)</li>\n        <li>**4.6** (2.4-8.7)</li>\n        <li>**3.1** (1.8-5.5)</li>\n      </ul>\n    </td>\n    <td>\n      <br>\n      <ul>\n        <li>0.74 (0.63-0.84)</li>\n        <li>0.83 (0.74-0.93)</li>\n        <li>0.84 (0.75-0.94)</li>\n      </ul>\n    </td>\n  </tr>\n  <tr>\n    <td>BNP lab ≥ 100 pg/mL </td>\n    <td>**4.1** (3.3-5.0)</td>\n    <td>**0.09** (0.04-0.19)</td>\n  </tr>\n</table>\n\n## BNP test characteristics to predict CHF in ED patients +/- asthma or COPD \n\n[Wang et al. (2005)](https://www.ncbi.nlm.nih.gov/pubmed/?term=16234501)\n\n| BNP level (pg/mL)  |  Positive LR  |  Negative LR     |\n|--------------------|---------------|------------------|\n| ≥ 250              | 4.6 (2.6-8.0) | 0.14 (0.06-0.33) |\n| ≥ 200              | 3.7 (2.6-5.4) | 0.11 (0.07-0.18) |\n| ≥ 150              | 3.1 (2.1-4.5) | 0.15 (0.11-0.21) |\n| ≥ 100              | 2.7 (2.0-3.9) | 0.11 (0.07-0.16) |\n| ≥ 80               | 3.3 (1.8-6.3) | 0.06 (0.03-0.13) |\n| ≥ 50               | 1.7 (1.2-2.6) | 0.06 (0.03-0.12) |\n\n## References\n\n-   [McCullough PA, Hollander JE, Nowak RM, Storrow AB, Duc P, Omland T, McCord J, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS; BNP Multinational Study Investigators. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med. 2003 Mar;10(3):198-204.](https://www.ncbi.nlm.nih.gov/pubmed/?term=12615582)\n-   [Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA. 2005 Oct 19;294(15):1944-56.](https://www.ncbi.nlm.nih.gov/pubmed/?term=16234501)\n"}}